↓ Skip to main content

Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis

Overview of attention for article published in BMC Pediatrics, October 2014
Altmetric Badge

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis
Published in
BMC Pediatrics, October 2014
DOI 10.1186/1471-2431-14-261
Pubmed ID
Authors

Leonard R Krilov, Anthony S Masaquel, Leonard B Weiner, David M Smith, Sally W Wade, Parthiv J Mahadevia

Abstract

Infection with respiratory syncytial virus (RSV) is common among young children insured through Medicaid in the United States. Complete and timely dosing with palivizumab is associated with lower risk of RSV-related hospitalizations, but up to 60% of infants who receive palivizumab in Medicaid population do not receive full prophylaxis. The purpose of this study was to evaluate the association of partial palivizumab prophylaxis with the risk of RSV hospitalization among high-risk Medicaid-insured infants.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 6%
Unknown 44 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 21%
Researcher 7 15%
Other 6 13%
Student > Ph. D. Student 5 11%
Student > Bachelor 4 9%
Other 5 11%
Unknown 10 21%
Readers by discipline Count As %
Medicine and Dentistry 20 43%
Nursing and Health Professions 4 9%
Social Sciences 3 6%
Agricultural and Biological Sciences 2 4%
Immunology and Microbiology 2 4%
Other 5 11%
Unknown 11 23%